Pandemic (influenza)

Tags 

In relation to the global effort to improve influenza pandemic preparedness, the generic

term “pandemic” has been interpreted specifically in relation to influenza and most

often refers to:

1. Phases 5-6 (Pandemic) of the phases of pandemic alert, published in the 2009

Pandemic Influenza Preparedness and Response: a WHO guidance document (1)

2. Pandemic phase, as defined in Pandemic Influenza Risk Management WHO

Interim Guidance, 2013 replacing the 2009 Pandemic Influenza Preparedness and

Response: a WHO guidance document, see below, (2)

As the Interim Guidance from 2013 replaces the 2009 Pandemic Influenza

Preparedness and Response Guidance, we provide an excerpt from the Interim

Guidance, clarifying the context and purpose of the term “pandemic phase”:

“The phases, which are based on virological, epidemiological and clinical data, are to

be used for describing the spread of a new influenza subtype, taking account of the

disease it causes, around the world. The global phases have been clearly uncoupled

from risk management decisions and actions at the country level. Thus, Member

States are encouraged as far as possible to use national risk assessments to inform

management decisions for the benefit of their country’s specific situation and needs

The global phases – interpandemic, alert, pandemic and transition – describe the

spread of the new influenza subtype, taking account of the disease it causes, around

the world. As pandemic viruses emerge, countries and regions face different risks at

different times. For that reason, countries are strongly advised to develop their own

national risk assessments based on local circumstances, taking into consideration the

information provided by the global assessments produced by WHO. Risk management

decisions by countries are therefore expected to be informed by global risk

assessments, but based on local risk assessments.

[…]

One of the underlying principles of this guidance is to acknowledge that emergency

risk management at country level needs to be sufficiently flexible to accommodate

different consequences within individual countries, for example, different severities and

different numbers of waves of illness. The global phases will be used by WHO to

communicate the global situation. They will be incorporated into IHR (2005) related

communications to National IHR Focal Points, in Disease Outbreak News releases and

various other public and media interactions, including through social media channels[…]

National actions:

The nature and scale of national actions at any point in time will be in line with the

current national risk assessments, taking into consideration the global risk assessment.

The uncoupling of national actions from global phases is necessary since the global

risk assessment, by definition, will not represent the situation in individual Member

States.[…]

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Engaging all of Europe in shaping a desirable and sustainable future
Expect the unexpected and know how to respond
Driving innovation in crisis management for European resilience
Effective communication in outbreak management: development of an evidence-based tool for Europe
Solutions to improve CBRNe resilience
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
Developing the framework for an epidemic forecast infrastructure
Strengthening of the national surveillance system for communicable diseases
Surveillance of vaccine preventable hepatitis
European monitoring of excess mortality for public health action
European network for highly infectious disease
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Addressing chronic diseases and healthy ageing across the life cycle
Medical ecosystem – personalized event-based surveillance
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
Get involved in the responsible marine research and innovation
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
Promote vaccinations among migrant population in Europe
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
Improve the quality of indoor air, keeping it free from radon
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
Investigating how cities in the West securitise against global pandemics
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
Identifying how children can be change agents in the Science and Society relationship
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence